Beta-blockers in patients with cirrhosis and ascites: type of beta-blocker matters

Gut. 2016 Aug;65(8):1393-4. doi: 10.1136/gutjnl-2016-312129. Epub 2016 May 20.

Authors

Basile Njei¹, Thomas R McCarty², Guadalupe Garcia-Tsao²

Affiliations

¹ Section of Digestive Diseases, Yale University School of Medicine, New Haven, Connecticut, USA Investigative Medicine Program, Yale Center of Clinical Investigation, New Haven, Connecticut, USA.
² Section of Digestive Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.

PMID: 27207973
DOI: 10.1136/gutjnl-2016-312129

No abstract available

Keywords: ASCITES; LIVER CIRRHOSIS.

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

MeSH terms

Adrenergic beta-Antagonists*
Ascites*
Fibrosis
Humans
Liver Cirrhosis

Substances

Adrenergic beta-Antagonists